Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

5-HT2A Receptor: A Newer Target for Obesity

Jignesh Patel1*, Krupali Mistry2, Anirudh Jain 3

1. Department of Pharmaceutics and Pharmaceutical Technology, SAL Institute of
    Pharmacy, Gujarat, India
2. Drug Inspector, Food and drug department,Gandhinagar, Gujarat, India.
3. Department of Pharmaceutics and Pharmaceutical Technology, SAL Institute of
    Pharmacy, Gujarat, India.

ABSTRACT

Obesity has become major worldwide health problems. Serotonin (5-hydroxytryptamine; 5-HT) is a neurotransmitter that contributes to the regulation of many physiological processes and abnormalities of the serotonergic system have been implicated in the pathogenesis of obesity. 5-HT2A receptor is belongs to Gprotein coupled receptor (GPCR), expressed widely throughout the central nervous system (CNS). Hypothalamic 5-HT2A receptors might have a role in the regulation of feeding and energy homeostasis. 5-HT2A receptor gene expression was increased in association with obesity. 5-HT2A receptor antagonism increases expression of adiponectin and decreases plasminogen activator inhibitor 1 (PAI-1) expression via the 5-HT2A receptor signaling cascade. Recently, development of 5- HT2A receptor antagonists as a novel therapeutic strategy for obesity and associated comorbidities has been the focus of much interest. Here, we describe the role of 5- HT2A receptor in pathogenesis of obesity.

Keywords: Obesity, serotonin, 5-HT2A receptor, sarpogrelate, adiponectin, PAI-1


[Full Text Article]